Möhle Robert, Kanz Lothar
Department of Medicine II, University of Tübingen, Tübingen, Germany.
Semin Hematol. 2007 Jul;44(3):193-202. doi: 10.1053/j.seminhematol.2007.04.006.
During inflammation and cytopenia, increased levels of hematopoietic growth factors (HPGFs) induce mobilization and proliferation of hematopoietic stem cells and hematopoietic progenitor cells (HPCs), resulting in spatial and quantitative in vivo expansion of the hematopoietic tissue. Exogenous administration of recombinant HPGFs, particularly granulocyte colony-stimulating factor (G-CSF), is routine for mobilization of stem cells, followed by collection and transplantation of autologous or allogeneic stem cells. In this review, we summarize experience using different HPGFs and HPGF combinations for stem cell mobilization, such as G-CSF, granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), stem cell factor (SCF), and others. Preclinical and clinical studies of so-called early- and late-acting HPGFs for ex vivo expansion of HPCs are discussed, also with respect to the unresolved question whether expansion of repopulating stem cells can be achieved in vitro.
在炎症和血细胞减少期间,造血生长因子(HPGFs)水平升高会诱导造血干细胞和造血祖细胞(HPCs)的动员和增殖,从而导致造血组织在体内的空间和数量上的扩张。外源性给予重组HPGFs,特别是粒细胞集落刺激因子(G-CSF),是干细胞动员的常规方法,随后进行自体或异基因干细胞的采集和移植。在本综述中,我们总结了使用不同的HPGFs和HPGF组合进行干细胞动员的经验,如G-CSF、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、白细胞介素-3(IL-3)、干细胞因子(SCF)等。还讨论了所谓的早期和晚期作用的HPGFs用于HPCs体外扩增的临床前和临床研究,以及关于是否能在体外实现再填充干细胞扩增这一未解决问题。